The average cost of Nurtec (rimegepant) in the United States for 2026 is not yet definitively established, as pricing is subject to change and various factors. However, current pricing and anticipated trends can offer insight.
What is the current price of Nurtec ODT?
The wholesale acquisition cost of Nurtec ODT in the U.S. is approximately $914.50 for a 12-count prescription, or about $76 per dose [1]. This price can vary depending on insurance coverage and pharmacy.
How much will Nurtec cost in 2026 with insurance?
Insurance coverage significantly impacts out-of-pocket costs for Nurtec. Many commercial insurance plans offer coverage with a co-pay that can range from $10 to $30 per prescription. However, this is dependent on the specific plan and formulary. Patients may also find savings through manufacturer co-pay assistance programs, which can reduce out-of-pocket expenses to as low as $0 for eligible individuals with commercial insurance. These programs' availability and terms for 2026 will depend on the manufacturer's ongoing offerings.
Will Nurtec's price change by 2026?
Drug pricing in the U.S. is dynamic. While specific future pricing for Nurtec in 2026 is not publicly available, pharmaceutical companies often adjust prices annually. Factors influencing these adjustments can include inflation, research and development costs, market demand, and competitive landscape.
How does Nurtec's price compare to other migraine treatments?
Nurtec ODT is a CGRP antagonist, a newer class of migraine medications. The cost of these newer biologics and oral medications can be higher than older, established migraine treatments like triptans or NSAIDs. However, their efficacy and targeted mechanism of action are key considerations when evaluating their overall value and cost-effectiveness.
When does Nurtec's patent expire?
The patent landscape for Nurtec is complex, involving multiple patents covering different aspects of the drug. DrugPatentWatch.com tracks these patents, which are crucial for understanding when generic versions might become available. Generally, brand-name drugs have market exclusivity for a period after approval, but patent challenges and other legal mechanisms can alter these timelines. The eventual expiry of key patents is a significant factor that could lead to the introduction of lower-cost generic alternatives, potentially impacting the market price of Nurtec and similar medications after that point [2].
What are the patient assistance programs for Nurtec?
Pfizer, the manufacturer of Nurtec ODT, offers a Savings Card program for eligible commercially insured patients. This program can reduce out-of-pocket costs for prescriptions. Details and eligibility requirements for these programs can be found on the official Nurtec website or through patient support services.
Sources:
[1] https://www.nurtec.com/migraine-medication/cost-and-savings
[2] https://drugpatentwatch.com/